Who Paid My Doc Search
Menu
Product Program year 2023 Source: CMS Open Payments

Instylla Microcatheter

Device Liquid Embolics for Interventional Radiology

PDI 00812013030055

Open in the dashboard

General payments

$122,707

92 payments

Research payments

$1,449,499

178 payments

Through program year 2023, $122,707 in general payments and $1,449,499 in research payments were reported against Instylla Microcatheter (Liquid Embolics for Interventional Radiology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 General $79,513 72
2023 Research $981,923 133
2022 General $43,194 20
2022 Research $467,576 45

Breakdown

Who paid General payments · program years 2022–2023
  1. Instylla Inc. $122,707 92 payments
Top recipients General payments · program year 2023
  1. Venkatesh Krishnasamy Vascular & Interventional Radiology · Birmingham, AL $17,337 22% · 6 payments
  2. David Tahour Vascular & Interventional Radiology · Long Beach, CA $17,000 21% · 6 payments
  3. Suvranu Ganguli Vascular & Interventional Radiology · Boston, MA $15,941 20% · 8 payments
  4. Kei Yamada Vascular & Interventional Radiology · Atlanta, GA $12,263 15% · 4 payments
  5. Nadine Abi-Jaoudeh Vascular & Interventional Radiology · Orange, CA $5,500 7% · 3 payments

The top 5 of 40 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Vascular & Interventional Radiology Radiology $78,265 98% · 30 practitioners
  2. Diagnostic Radiology Radiology $1,147 1% · 8 practitioners
  3. Pediatric Radiology Radiology $78 <1% · 1 practitioner
  4. Pulmonary Disease Internal Medicine $23 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. California $22,713 29% · 3 recipients
  2. Massachusetts $18,070 23% · 4 recipients
  3. Alabama $17,337 22% · 1 recipient
  4. Georgia $12,293 15% · 2 recipients
  5. Arkansas $4,828 6% · 3 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

Records

92 general · 178 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record